ZK INTERNATIONAL GROUP CO LT (ZKIN) Fundamental Analysis & Valuation

NASDAQ:ZKIN • VGG9892K2092

Current stock price

1.68 USD
0 (0%)
Last:

This ZKIN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ZKIN Profitability Analysis

1.1 Basic Checks

  • In the past year ZKIN has reported negative net income.
  • ZKIN had a positive operating cash flow in the past year.
  • ZKIN had negative earnings in each of the past 5 years.
  • ZKIN had negative operating cash flow in 4 of the past 5 years.
ZKIN Yearly Net Income VS EBIT VS OCF VS FCFZKIN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20M -40M -60M

1.2 Ratios

  • ZKIN has a Return On Assets of -6.34%. This is in the lower half of the industry: ZKIN underperforms 63.19% of its industry peers.
  • The Return On Equity of ZKIN (-16.27%) is worse than 66.26% of its industry peers.
Industry RankSector Rank
ROA -6.34%
ROE -16.27%
ROIC N/A
ROA(3y)-37.96%
ROA(5y)-24.29%
ROE(3y)-89.87%
ROE(5y)-56.22%
ROIC(3y)N/A
ROIC(5y)N/A
ZKIN Yearly ROA, ROE, ROICZKIN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150 -200

1.3 Margins

  • ZKIN has a Gross Margin of 5.67%. This is in the lower half of the industry: ZKIN underperforms 64.42% of its industry peers.
  • ZKIN's Gross Margin has improved in the last couple of years.
  • ZKIN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.58%
GM growth 5Y4.77%
ZKIN Yearly Profit, Operating, Gross MarginsZKIN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. ZKIN Health Analysis

2.1 Basic Checks

  • ZKIN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ZKIN has been increased compared to 1 year ago.
  • The number of shares outstanding for ZKIN has been increased compared to 5 years ago.
  • Compared to 1 year ago, ZKIN has a worse debt to assets ratio.
ZKIN Yearly Shares OutstandingZKIN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
ZKIN Yearly Total Debt VS Total AssetsZKIN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • Based on the Altman-Z score of 1.63, we must say that ZKIN is in the distress zone and has some risk of bankruptcy.
  • ZKIN has a Altman-Z score of 1.63. This is in the lower half of the industry: ZKIN underperforms 75.46% of its industry peers.
  • The Debt to FCF ratio of ZKIN is 324.85, which is on the high side as it means it would take ZKIN, 324.85 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of ZKIN (324.85) is comparable to the rest of the industry.
  • ZKIN has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
  • With a Debt to Equity ratio value of 0.47, ZKIN is not doing good in the industry: 71.78% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 324.85
Altman-Z 1.63
ROIC/WACCN/A
WACC10.97%
ZKIN Yearly LT Debt VS Equity VS FCFZKIN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 1.44 indicates that ZKIN should not have too much problems paying its short term obligations.
  • ZKIN has a Current ratio of 1.44. This is in the lower half of the industry: ZKIN underperforms 74.85% of its industry peers.
  • A Quick Ratio of 1.02 indicates that ZKIN should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.02, ZKIN is not doing good in the industry: 68.71% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1.02
ZKIN Yearly Current Assets VS Current LiabilitesZKIN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. ZKIN Growth Analysis

3.1 Past

  • ZKIN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.19%.
  • Looking at the last year, ZKIN shows a very negative growth in Revenue. The Revenue has decreased by -34.16% in the last year.
  • Measured over the past years, ZKIN shows a decrease in Revenue. The Revenue has been decreasing by -3.87% on average per year.
EPS 1Y (TTM)-24.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20.56%
Revenue 1Y (TTM)-34.16%
Revenue growth 3Y-11.39%
Revenue growth 5Y-3.87%
Sales Q2Q%-43.51%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZKIN Yearly Revenue VS EstimatesZKIN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

Find the best growth stocksShow best growing peers

1

4. ZKIN Valuation Analysis

4.1 Price/Earnings Ratio

  • ZKIN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZKIN Price Earnings VS Forward Price EarningsZKIN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • ZKIN's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 1140.77
EV/EBITDA N/A
ZKIN Per share dataZKIN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ZKIN Dividend Analysis

5.1 Amount

  • ZKIN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ZKIN Fundamentals: All Metrics, Ratios and Statistics

ZK INTERNATIONAL GROUP CO LT

NASDAQ:ZKIN (4/27/2026, 1:06:38 PM)

1.68

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-16
Earnings (Next)N/A
Inst Owners0.09%
Inst Owner Change0%
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap96.28M
Revenue(TTM)71.24M
Net Income(TTM)-3.99M
Analysts0
Price TargetN/A
Short Float %0.13%
Short Ratio4.74
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.35
P/FCF 1140.77
P/OCF 130.75
P/B 3.93
P/tB 4.13
EV/EBITDA N/A
EPS(TTM)-0.67
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY0.09%
OCF(TTM)0.01
OCFY0.76%
SpS1.24
BVpS0.43
TBVpS0.41
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -6.34%
ROE -16.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.67%
FCFM 0.12%
ROA(3y)-37.96%
ROA(5y)-24.29%
ROE(3y)-89.87%
ROE(5y)-56.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.58%
GM growth 5Y4.77%
F-Score3
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 324.85
Debt/EBITDA N/A
Cap/Depr 75.02%
Cap/Sales 0.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 1.02
Altman-Z 1.63
F-Score3
WACC10.97%
ROIC/WACCN/A
Cap/Depr(3y)127.07%
Cap/Depr(5y)145.32%
Cap/Sales(3y)1.18%
Cap/Sales(5y)1.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20.56%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-34.16%
Revenue growth 3Y-11.39%
Revenue growth 5Y-3.87%
Sales Q2Q%-43.51%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-124%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y101.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y110.71%
OCF growth 3YN/A
OCF growth 5Y9.87%

ZK INTERNATIONAL GROUP CO LT / ZKIN Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ZK INTERNATIONAL GROUP CO LT?

ChartMill assigns a fundamental rating of 1 / 10 to ZKIN.


What is the valuation status of ZK INTERNATIONAL GROUP CO LT (ZKIN) stock?

ChartMill assigns a valuation rating of 1 / 10 to ZK INTERNATIONAL GROUP CO LT (ZKIN). This can be considered as Overvalued.


What is the profitability of ZKIN stock?

ZK INTERNATIONAL GROUP CO LT (ZKIN) has a profitability rating of 1 / 10.